Post by
mercedesman on Feb 23, 2022 12:15pm
Theory
Based on my theory that the SP will roughly track the Tigris enrollment, it would appear thta we were up to 40 patients, briefly, but that 7 have dropped out of the Trial.
Not to worry though as with clearing ICU's all across the US I see enrollment moving to 8 or 10 per month soon.
Using the low side of the estimate, that could put us near 65 enrollees by the start of summer.
DIMI?
per recent release
"Based on the approved protocol amendment, we are now progressing to the site contracting phase, which we expect will provide greater visibility on the revised DIMI trial timeline.”
My theory here is that we will add a penny per DIMI Trial enrollee as well.
So if we add 20 DIMI Trial enrollees by start of summer, the SP should be .65 + .20 = .85 (157% upside based on today's price)...but still wildly conservative in relation to Paradigm's latest.
(debated about using 2 cents per enrollee based on DIMI being a "when not IF, approval", and $ 2B valuations for lesser competitor pumps, but decided to take a more conservative approach)
That's my theory, and I'm sticking to it. Based on science. With a 95% margin of error.
MM
Comment by
Domino55 on Feb 23, 2022 1:39pm
Promising "when's and Multiples" and delivering a valuation of "ifs and fractions". If only we had a CEO that understood business rather than medicine only... It seems we have flown to close to the Sun. Off a healthy 10% in market cap since Thursday's investigators meeting. Good Lord this is exciting.